BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Prognosis
253 results:

  • 1. Prognostic Implications of Small Cell Lung cancer Transcriptional Subtyping for CNS Metastases.
    Tringale KR; Skakodub A; Egger J; Eichholz J; Yu Y; Gomez D; Rimner A; Li B; Yamada Y; Wilcox J; Moss N; Imber BS; Rekhtman N; Baine MK; Rudin CM; Pike LRG
    JCO Precis Oncol; 2024 Apr; 8():e2300470. PubMed ID: 38691815
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. An analysis of neutrophil-to-lymphocyte ratios and monocyte-to-lymphocyte ratios with six-month prognosis after cerebral contusions.
    Zhang D; Zhuang D; Li T; Liu X; Zhang Z; Zhu L; Tian F; Chen X; Li K; Chen W; Sheng J
    Front Immunol; 2024; 15():1336862. PubMed ID: 38545111
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Tumor Treating Fields (TTFields) combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro.
    Cao Q; Hajosch A; Kast RE; Loehmann C; Hlavac M; Fischer-Posovszky P; Strobel H; Westhoff MA; Siegelin MD; Wirtz CR; Halatsch ME; Karpel-Massler G
    Br J Cancer; 2024 May; 130(8):1365-1376. PubMed ID: 38396172
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Endometrial cancer: A Review on Immunohistochemistry Staining Patterns and Clinical Implications.
    Addante F; d'Amati A; Santoro A; Angelico G; Inzani F; Arciuolo D; Travaglino A; Raffone A; D'Alessandris N; Scaglione G; Valente M; Tinnirello G; Sfregola S; Padial Urtueta B; Piermattei A; Cianfrini F; Mulè A; Bragantini E; Zannoni GF
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256131
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinical features, etiologies, and outcomes of central nervous system infections in intensive care: A multicentric retrospective study in a large Brazilian metropolitan area.
    Andrade HB; da Silva IRF; Espinoza R; Ferreira MT; da Silva MST; Theodoro PHN; Detepo PJT; Varela MC; Ramos GV; da Silva AR; Soares J; Belay ED; Sejvar JJ; Bozza FA; Cerbino-Neto J; Japiassú AM
    J Crit Care; 2024 Feb; 79():154451. PubMed ID: 37871403
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Survival and neurological outcomes after stereotactic biopsy of diffuse intrinsic pontine glioma: a systematic review.
    Dalmage M; LoPresti MA; Sarkar P; Ranganathan S; Abdelmageed S; Pagadala M; Shlobin NA; Lam S; DeCuypere M
    J Neurosurg Pediatr; 2023 Dec; 32(6):665-672. PubMed ID: 37724839
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Mismatch Repair Deficiency in Biliary Tract cancer: Prognostic Implications and Correlation with Histology.
    Vivaldi C; Genovesi V; Ugolini C; Bernardini L; Casadei-Gardini A; Formica V; Salani F; Orsi G; Massa V; Cacciato-Insilla A; Caccese M; Cesario S; Andrikou K; Graziani J; Campani D; Vasile E; Fontanini G; Fornaro L; Masi G
    Oncology; 2024; 102(2):157-167. PubMed ID: 37699372
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: a phase 1, first-in-human trial.
    Umemura Y; Orringer D; Junck L; Varela ML; West MEJ; Faisal SM; Comba A; Heth J; Sagher O; Leung D; Mammoser A; Hervey-Jumper S; Zamler D; Yadav VN; Dunn P; Al-Holou W; Hollon T; Kim MM; Wahl DR; Camelo-Piragua S; Lieberman AP; Venneti S; McKeever P; Lawrence T; Kurokawa R; Sagher K; Altshuler D; Zhao L; Muraszko K; Castro MG; Lowenstein PR
    Lancet Oncol; 2023 Sep; 24(9):1042-1052. PubMed ID: 37657463
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Dissection of transcriptomic and epigenetic heterogeneity of grade 4 gliomas: implications for prognosis.
    Zeng C; Song X; Zhang Z; Cai Q; Cai J; Horbinski C; Hu B; Cheng SY; Zhang W
    Acta Neuropathol Commun; 2023 Aug; 11(1):133. PubMed ID: 37580817
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Management and Long-term Outcomes of Adults With Medulloblastoma: A Single-Center Experience.
    Neth BJ; Raghunathan A; Kizilbash SH; Uhm JH; Breen WG; Johnson DR; Daniels DJ; Sener U; Carabenciov ID; Campian JL; Khatua S; Mahajan A; Ruff MW
    Neurology; 2023 Sep; 101(12):e1256-e1271. PubMed ID: 37524533
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY brain Tumor Funders' Collaborative Consortium (EORTC 1419).
    Hertler C; Felsberg J; Gramatzki D; Le Rhun E; Clarke J; Soffietti R; Wick W; Chinot O; Ducray F; Roth P; McDonald K; Hau P; Hottinger AF; Reijneveld J; Schnell O; Marosi C; Glantz M; Darlix A; Lombardi G; Krex D; Glas M; Reardon DA; van den Bent M; Lefranc F; Herrlinger U; Razis E; Carpentier AF; Phillips S; Rudà R; Wick A; Tabouret E; Meyronet D; Maurage CA; Rushing E; Rapkins R; Bumes E; Hegi M; Weyerbrock A; Aregawi D; Gonzalez-Gomez C; Pellerino A; Klein M; Preusser M; Bendszus M; Golfinopoulos V; von Deimling A; Gorlia T; Wen PY; Reifenberger G; Weller M
    Eur J Cancer; 2023 Aug; 189():112913. PubMed ID: 37277265
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Assessment of Social Vulnerability in Pediatric Head and Neck cancer Care and prognosis in the United States.
    Fei-Zhang DJ; Chelius DC; Patel UA; Smith SS; Sheyn AM; Rastatter JC
    JAMA Netw Open; 2023 Feb; 6(2):e230016. PubMed ID: 36800183
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. brain metastases in Japanese NSCLC patients: prognostic assessment and the use of osimertinib and immune checkpoint inhibitors-retrospective study.
    Higaki H; Nishioka K; Otsuka M; Nishikawa N; Shido M; Minatogawa H; Nishikawa Y; Takashina R; Hashimoto T; Katoh N; Taguchi H; Kinoshita R; Yasuda K; Mori T; Uchinami Y; Koizumi F; Fujita Y; Takahashi S; Hattori T; Nishiyama N; Aoyama H
    Radiat Oncol; 2023 Feb; 18(1):25. PubMed ID: 36750899
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Defining the Phenotype and prognosis of People With Idiopathic Intracranial Hypertension After Cerebrospinal Fluid Diversion Surgery.
    Hyder YF; Homer V; Thaller M; Byrne M; Tsermoulas G; Piccus R; Mollan SP; Sinclair AJ
    Am J Ophthalmol; 2023 Jun; 250():70-81. PubMed ID: 36682516
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of brain Lymphomas.
    Mutter JA; Alig SK; Esfahani MS; Lauer EM; Mitschke J; Kurtz DM; Kühn J; Bleul S; Olsen M; Liu CL; Jin MC; Macaulay CW; Neidert N; Volk T; Eisenblaetter M; Rauer S; Heiland DH; Finke J; Duyster J; Wehrle J; Prinz M; Illerhaus G; Reinacher PC; Schorb E; Diehn M; Alizadeh AA; Scherer F
    J Clin Oncol; 2023 Mar; 41(9):1684-1694. PubMed ID: 36542815
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Recurrent pediatric infratentorial ependymomas: a systematic review and meta-analysis on outcomes and molecular classification.
    Montgomery EY; Thirunavu V; Pagadala M; Shlobin NA; Plant-Fox AS; Lam S; DeCuypere M
    J Neurosurg Pediatr; 2023 Feb; 31(2):132-142. PubMed ID: 36433871
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Incidence proportion and prognosis of leptomeningeal disease among patients with breast vs. non-breast primaries.
    Lamba N; Cagney DN; Catalano PJ; Elhalawani H; Haas-Kogan DA; Wen PY; Wagle N; Lin NU; Aizer AA; Tanguturi S
    Neuro Oncol; 2023 May; 25(5):973-983. PubMed ID: 36367837
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Inhibition of glioblastoma proliferation, invasion, and migration by Urolithin B through inducing G0/G1 arrest and targeting MMP-2/-9 expression and activity.
    Eidizade F; Soukhtanloo M; Zhiani R; Mehrzad J; Mirzavi F
    Biofactors; 2023 Mar; 49(2):379-389. PubMed ID: 36310375
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Cluster Analysis of DSC MRI, Dynamic Contrast-Enhanced MRI, and DWI Parameters Associated with prognosis in Patients with Glioblastoma after Removal of the Contrast-Enhancing Component: A Preliminary Study.
    Chung H; Seo H; Choi SH; Park CK; Kim TM; Park SH; Won JK; Lee JH; Lee ST; Lee JY; Hwang I; Kang KM; Yun TJ
    AJNR Am J Neuroradiol; 2022 Nov; 43(11):1559-1566. PubMed ID: 36175084
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Outcomes and Molecular Features of brain Metastasis in Gastroesophageal Adenocarcinoma.
    Tsai C; Nguyen B; Luthra A; Chou JF; Feder L; Tang LH; Strong VE; Molena D; Jones DR; Coit DG; Ilson DH; Ku GY; Cowzer D; Cadley J; Capanu M; Schultz N; Beal K; Moss NS; Janjigian YY; Maron SB
    JAMA Netw Open; 2022 Aug; 5(8):e2228083. PubMed ID: 36001319
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 13.